PF-06669571 In Subjects With Idiopathic Parkinson's Disease

NCT02565628 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer